Ultrastructural and hormonal changes in the pineal-testicular axis following arecoline administration in rats.
Arecoline is an alkaloid of betel nut of Areca catechu. Betel nut is chewed by millions of people in the world and it causes oral and hepatic cancers in human. It has therapeutic value for the treatment of Alzheimer and schizophrenia. Arecoline has immunosuppressive, mutagenic and genotoxic effects in laboratory animals. It also affects endocrine functions. The objective of this study was to investigate the effects of arecoline on pineal-testicular axis in rats. Since pineal activity is different between day and night, the current study is undertaken in both the photophase and scotophase. The findings were evaluated by ultrastructural and hormonal studies of pineal and testicular Leydig cells, with quantitations of fructose and sialic acid of sex accessories. Arecoline treatment (10 mg/kg body weight daily for 10 days) caused suppression of pineal activity at ultrastructural level by showing dilatation of the cisternae of the rough endoplasmic reticulum (RER), large autophagosome-like bodies with swollen mitochondrial cristae, numerous lysosomes, degenerated synaptic ribbons and reduced number of synaptic-like microvesicles. Moreover, pineal and serum N-acetylserotonin and melatonin levels were decreased with increased serotonin levels in both the gland and serum. In contrast, testicular Leydig cell activity was stimulated with abundance of smooth endoplasmic reticulum (SER), electron-dense core vesicles and vacuolated secretory vesicles, and increased testosterone level in the arecoline recipients. Consequently, the testosterone target, like prostate, was ultrastructurally stimulated with abundance of RER and accumulation of secretory vesicles. Fructose and sialic acid concentrations were also significantly increased respectively in the coagulating gland and seminal vesicle. These results were more significant in the scotophase than the photophase. The findings suggest that arecoline inhibits pineal activity, but stimulates testicular function (testosterone level) and its target organs presumably via muscarinic cholinergic receptor in rats.
Saha
Indraneel
I
Department of Zoology, University of Calcutta, Calcutta, India.
Chatterji
Urmi
U
Chaudhuri-Sengupta
Santasri
S
Nag
Tapas C
TC
Nag
Debabrata
D
Banerjee
Samir
S
Maiti
B R
BR
D000818:Animals; D001115:Arecoline / Q000008:administration & dosage / Q000494:pharmacology*; D018679:Cholinergic Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D005632:Fructose / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007985:Leydig Cells / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D008297:Male; D008550:Melatonin / Q000378:metabolism; D019158:N-Acetylneuraminic Acid / Q000378:metabolism; D017440:Photoperiod; D010870:Pineal Gland / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D011467:Prostate / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000031:analogs & derivatives / Q000378:metabolism; D013737:Testis / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D013739:Testosterone / Q000378:metabolism
D018679:Cholinergic Agonists; D005632:Fructose; D012701:Serotonin; D013739:Testosterone; D001115:Arecoline; D019158:N-Acetylneuraminic Acid; D008550:Melatonin; C006389:N-acetylserotonin